Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor

Summary

Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor is a clinical trial^[1].

Key Facts

• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor is in the country of Netherlands^[2].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's instance of is recorded as clinical trial^[3].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's start time is recorded as +2015-05-31T00:00:00Z^[4].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's end time is recorded as +2017-10-31T00:00:00Z^[5].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's sponsor is recorded as VU University Medical Center^[6].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's main subject is recorded as myocardial infarction^[7].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's number of participants is recorded as {'unit': '1', 'amount': '+110'}^[8].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's title is recorded as Reducing Micro Vascular Dysfunction In Revascularized ST-elevation Myocardial Infarction Patients by Off-target Properties of Ticagrelor^[9].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's short name is recorded as REDUCE-MVI^[10].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's ClinicalTrials.gov ID is recorded as NCT02422888^[12].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+74'}^[13].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's research intervention is recorded as prasugrel hydrochloride^[14].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's clinical trial phase is recorded as phase IV clinical trial^[15].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's research site is recorded as Vrije Universiteit Amsterdam^[16].
• Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor's study type is recorded as interventional study^[17].